FilingSEC EDGAR8-K
Aprea Therapeutics Expands Intellectual Property Portfolio for Precision Oncology Programs
· SEC accepted
StagePhase 1
Filing content
Aprea Therapeutics announced the expansion of its intellectual property portfolio for precision oncology programs, now holding 28 issued patents and 30 pending patent applications.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…